+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Immunochemicals - Global Market Trajectory & Analytics

  • ID: 4426701
  • Report
  • April 2021
  • Region: Global
  • Global Industry Analysts, Inc

FEATURED COMPANIES

  • Abcam Plc.
  • Beckman Coulter GmbH
  • Biolegend Inc.
  • Bio-Rad Laboratories Inc.
  • PerkinElmer Inc.
  • Sigma-Aldrich Corporation
  • MORE
Global Immunochemicals Market to Reach $5.3 Billion by 2027

Amid the COVID-19 crisis, the global market for Immunochemicals estimated at US$3.7 Billion in the year 2020, is projected to reach a revised size of US$5.3 Billion by 2027, growing at a CAGR of 5.3% over the period 2020-2027. Catalog Antibodies, one of the segments analyzed in the report, is projected to record 4.6% CAGR and reach US$3.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Custom Antibodies segment is readjusted to a revised 6.9% CAGR for the next 7-year period.



The U.S. Market is Estimated at $1.1 Billion, While China is Forecast to Grow at 5% CAGR

The Immunochemicals market in the U.S. is estimated at US$1.1 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$929.7 Million by the year 2027 trailing a CAGR of 5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5% and 4.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Select Competitors (Total 116 Featured):
  • Abcam Plc.
  • Agilent Research Laboratories
  • Beckman Coulter GmbH
  • Biolegend Inc.
  • Bio-Rad Laboratories Inc.
  • Cell Signaling Technology Inc.
  • GenScript Biotech Corporation
  • PerkinElmer Inc.
  • Rockland Immunochemicals Inc.
  • Santa Cruz Biotechnology Inc.
  • Sigma-Aldrich Corporation
  • Thermo Fischer Scientific Inc.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abcam Plc.
  • Beckman Coulter GmbH
  • Biolegend Inc.
  • Bio-Rad Laboratories Inc.
  • PerkinElmer Inc.
  • Sigma-Aldrich Corporation
  • MORE
I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Immunochemicals - A Prelude
  • Recent Market Activity
  • Research Antibodies Market: Critical Role in Drug Discovery and Research
  • Key Factors Influencing Purchasing Decisions
  • Citations: One of the Key Factors Driving Research Antibodies’ Purchase
  • The US Dominates the Global Immunochemicals Market
  • Emerging Markets Offer Huge Potential
  • Catalog Antibodies - The Largest Market Segment
  • Custom Antibodies: Finding Favor in Research Applications
  • Primary Antibodies Dominate the Market
  • Competitive Scenario
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
  • Abcam Plc. (UK)
  • Agilent Research Laboratories (USA)
  • Biolegend, Inc. (USA)
  • Bio-Rad Laboratories, Inc. (USA)
  • Cell Signaling Technology, Inc. (USA)
  • GenScript Biotech Corporation
  • PerkinElmer, Inc. (USA)
  • Rockland Immunochemicals, Inc. (USA)
  • Santa Cruz Biotechnology, Inc. (USA)
  • Merck (Sigma-Aldrich Corporation) (USA)
  • Thermo Fisher Scientific Inc. (USA)
3. MARKET TRENDS & DRIVERS
  • Increasing Research Funding Bolsters Market Growth
  • Chinese Market to Become the Largest Investor in Basic Research
  • Cancer Research Drives the Global Immunochemicals Market
  • Cancer Ranks Among the Top Ten Causes of Death Worldwide
  • ‘Reproducibility Crisis’ of Antibodies - A Major Cause of Concern
  • Proper Validation of Antibodies - Vendor Do their Part
  • New Technologies for Antibodies Validation
  • Personalized Medicine Offers New Growth Avenues
  • Rabbit Monoclonal Antibodies Score over Other Animal Antibodies
  • Researchers Prefer Commercial Research to Academic Research
  • Increasing Collaborations between Industry and Academia
  • Beckman Coulter GmbH (USA)
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Current & Future Analysis for Immunochemicals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 2: World Historic Review for Immunochemicals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 3: World 15-Year Perspective for Immunochemicals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
  • Table 4: World Current & Future Analysis for Catalog Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 5: World Historic Review for Catalog Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 6: World 15-Year Perspective for Catalog Antibodies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • Table 7: World Current & Future Analysis for Custom Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 8: World Historic Review for Custom Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 9: World 15-Year Perspective for Custom Antibodies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
III. MARKET ANALYSIS
  • UNITED STATES
  • Table 10: USA Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 11: USA Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 12: USA 15-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2020 & 2027
  • CANADA
  • Table 13: Canada Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 14: Canada Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 15: Canada 15-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2020 & 2027
  • JAPAN
  • Table 16: Japan Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 17: Japan Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 18: Japan 15-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2020 & 2027
  • CHINA
  • Table 19: China Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 20: China Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 21: China 15-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2020 & 2027
  • EUROPE
  • Table 22: Europe Current & Future Analysis for Immunochemicals by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 23: Europe Historic Review for Immunochemicals by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 24: Europe 15-Year Perspective for Immunochemicals by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
  • Table 25: Europe Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 26: Europe Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 27: Europe 15-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2020 & 2027
  • FRANCE
  • Table 28: France Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 29: France Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 30: France 15-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2020 & 2027
  • GERMANY
  • Table 31: Germany Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 32: Germany Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 33: Germany 15-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2020 & 2027
  • ITALY
  • Table 34: Italy Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 35: Italy Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 36: Italy 15-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
  • Table 37: UK Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 38: UK Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 39: UK 15-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2020 & 2027
  • REST OF EUROPE
  • Table 40: Rest of Europe Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 41: Rest of Europe Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 42: Rest of Europe 15-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
  • Table 43: Asia-Pacific Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 44: Asia-Pacific Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 45: Asia-Pacific 15-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2020 & 2027
  • REST OF WORLD
  • Table 46: Rest of World Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 47: Rest of World Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 48: Rest of World 15-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2020 & 2027
IV. COMPETITION
  • Total Companies Profiled: 116
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Abcam Plc.
  • Agilent Research Laboratories
  • Beckman Coulter GmbH
  • Biolegend Inc.
  • Bio-Rad Laboratories Inc.
  • Cell Signaling Technology Inc.
  • GenScript Biotech Corporation
  • PerkinElmer Inc.
  • Rockland Immunochemicals Inc.
  • Santa Cruz Biotechnology Inc.
  • Sigma-Aldrich Corporation
  • Thermo Fischer Scientific Inc.
Note: Product cover images may vary from those shown
Adroll
adroll